Nicole E. Rich

6.1k total citations · 4 hit papers
107 papers, 3.7k citations indexed

About

Nicole E. Rich is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Nicole E. Rich has authored 107 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Hepatology, 74 papers in Epidemiology and 20 papers in Oncology. Recurrent topics in Nicole E. Rich's work include Liver Disease Diagnosis and Treatment (67 papers), Hepatocellular Carcinoma Treatment and Prognosis (58 papers) and Liver Disease and Transplantation (41 papers). Nicole E. Rich is often cited by papers focused on Liver Disease Diagnosis and Treatment (67 papers), Hepatocellular Carcinoma Treatment and Prognosis (58 papers) and Liver Disease and Transplantation (41 papers). Nicole E. Rich collaborates with scholars based in United States, Canada and Spain. Nicole E. Rich's co-authors include Amit G. Singal, Neehar D. Parikh, Jorge A. Marrero, Adam C. Yopp, Akbar K. Waljee, Mobolaji Odewole, Caitlin C. Murphy, Arjmand Mufti, Ju Dong Yang and Erin Wolf and has published in prestigious journals such as Gastroenterology, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Nicole E. Rich

97 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

2018 770 citations Nicole E. Rich, Neehar D. Parikh et al. Gastroenterology profile →
Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis

2017 339 citations Nicole E. Rich, Arjmand Mufti et al. Clinical Gastroenterology and Hepatology profile →
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

2022 246 citations Amit G. Singal, Nicole E. Rich et al. Journal of Hepatology profile →
Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta‐Analysis

2020 210 citations Nicole E. Rich, Jorge A. Marrero et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicole E. Rich United States	32	2.5k	2.4k	665	510	422	107	3.7k
Zhigang Duan United States	29	1.4k 0.5×	1.6k 0.7×	1.1k 1.6×	740 1.5×	302 0.7×	68	3.7k
Sarah Berhane United Kingdom	20	2.5k 1.0×	1.9k 0.8×	756 1.1×	569 1.1×	358 0.8×	41	4.2k
Arndt Weinmann Germany	32	1.7k 0.7×	1.1k 0.5×	716 1.1×	457 0.9×	602 1.4×	161	3.3k
Angelo Sangiovanni Italy	36	4.7k 1.8×	3.8k 1.6×	752 1.1×	570 1.1×	577 1.4×	124	6.1k
Alessandro Vitale Italy	37	2.8k 1.1×	1.8k 0.7×	778 1.2×	488 1.0×	374 0.9×	204	4.1k
Vatche G. Agopian United States	38	2.9k 1.1×	1.7k 0.7×	846 1.3×	633 1.2×	517 1.2×	131	5.0k
Carlos Rodríguez de Lope Spain	19	3.2k 1.3×	1.9k 0.8×	561 0.8×	538 1.1×	390 0.9×	38	4.0k
Parissa Tabrizian United States	28	1.9k 0.8×	984 0.4×	697 1.0×	581 1.1×	331 0.8×	107	3.3k
Catherine Frenette United States	25	1.2k 0.5×	917 0.4×	280 0.4×	185 0.4×	202 0.5×	87	1.8k
Janice H. Jou United States	17	1.3k 0.5×	1.4k 0.6×	182 0.3×	139 0.3×	174 0.4×	43	2.1k

Countries citing papers authored by Nicole E. Rich

Since Specialization

Citations

This map shows the geographic impact of Nicole E. Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole E. Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole E. Rich more than expected).

Fields of papers citing papers by Nicole E. Rich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole E. Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole E. Rich. The network helps show where Nicole E. Rich may publish in the future.

Co-authorship network of co-authors of Nicole E. Rich

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole E. Rich. A scholar is included among the top collaborators of Nicole E. Rich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole E. Rich. Nicole E. Rich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quirk, Lisa, J TERRELL, Fasiha Kanwal, et al.. (2025). Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD Cirrhosis. Cancers. 17(23). 3835–3835.

Guo, Jason, Andrew D. Shubin, Malcolm MacConmara, et al.. (2025). Transplantation of Patients with Hepatocellular Carcinoma Through Increased Utilization of Machine Perfusion Technology. Transplantation Direct. 11(4). e1777–e1777. 2 indexed citations

Yokoo, Takeshi, Darine Daher, Matthew S. Davenport, et al.. (2025). Multicenter evaluation of abbreviated MRI and ultrasound for detecting early-stage hepatocellular carcinoma. JHEP Reports. 7(5). 101357–101357.

Ahn, Joseph, Wee Han Ng, Yee Hui Yeo, et al.. (2025). Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation. Hepatology. 83(2). 249–260. 3 indexed citations

Daher, Darine, Nicole E. Rich, Nabihah Tayob, et al.. (2024). Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients. JAMA Network Open. 7(4). e248755–e248755. 12 indexed citations

Louissaint, Jeremy, John Deng, Robert W. Turer, et al.. (2024). Patients With Cirrhosis Rapidly Review Potentially Abnormal Hepatocellular Carcinoma Surveillance Results Through the Patient Portal. The American Journal of Gastroenterology. 119(11). 2331–2333. 3 indexed citations

Rich, Nicole E., Jeremy Louissaint, William M. Lee, et al.. (2024). Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis. Hepatology Communications. 8(4). 12 indexed citations

Singal, Amit G., Marco Sanduzzi‐Zamparelli, Pierre Nahon, et al.. (2023). International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance. Journal of Hepatology. 79(1). 226–239. 51 indexed citations

Karim, Mohammad A., Amit G. Singal, Hye‐Chung Kum, et al.. (2023). Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis. Cancer Research Communications. 3(5). 874–883. 4 indexed citations

10.

García–Tsao, Guadalupe, Juan G. Abraldeṣ, Nicole E. Rich, & Vincent Wai‐Sun Wong. (2023). AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. Gastroenterology. 166(1). 202–210. 31 indexed citations

11.

Yokoo, Takeshi, Neehar D. Parikh, Barton Lane, et al.. (2023). Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma. Radiology. 307(2). e220917–e220917. 41 indexed citations

12.

Daher, Darine, Nicole E. Rich, Ju Dong Yang, et al.. (2023). Multidisciplinary care for patients with HCC: a systematic review and meta-analysis. Hepatology Communications. 7(5). 44 indexed citations

13.

Wagle, Nikita Sandeep, David Washburn, Robert L. Ohsfeldt, et al.. (2022). Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States. Clinical Gastroenterology and Hepatology. 21(5). 1281–1292.e10. 21 indexed citations

14.

Jiao, Jingjing, Suet‐Ying Kwan, Lucas Veillon, et al.. (2021). Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prevention Research. 14(10). 955–962. 34 indexed citations

15.

Wagle, Nikita Sandeep, David Washburn, Robert L. Ohsfeldt, et al.. (2021). Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma. Hepatology Communications. 6(5). 1186–1197. 47 indexed citations

16.

Rich, Nicole E., Samuel Phen, Adam C. Yopp, et al.. (2021). Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis. Clinical Gastroenterology and Hepatology. 20(5). e1157–e1169. 28 indexed citations

17.

Gopal, Purva, Nicole E. Rich, Adam C. Yopp, et al.. (2020). Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis. Gut. 70(2). gutjnl–2020. 105 indexed citations

18.

Liu, Po‐Hong, Chia‐Yang Hsu, Chien‐Wei Su, et al.. (2020). Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver International. 40(10). 2522–2534. 31 indexed citations

19.

Rich, Nicole E., Christian Carr, Adam C. Yopp, Jorge A. Marrero, & Amit G. Singal. (2020). Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 20(2). e267–e288. 63 indexed citations

20.

Singal, Amit G., et al.. (2020). Racial and Sex Disparities in Hepatocellular Carcinoma in the USA. Current Hepatology Reports. 19(4). 462–469. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact